Unlock this StockReport nowClick to Unlock


BQE 580p 0.0  0.0%
11/12/18 1.50k

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 4th Jun, paid: 2nd Jul more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +10.1%

FINANCIAL BRIEF: For the six months ended 30 June 2018, Bioquell plc revenues increased 9% to £15.7M. Net income increased 39% to £1.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Investment revenues increase of 9% to £121K (income). Basic Earnings per Share excluding Extraordinary Items increased from £0.06 to £0.08. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 30th Jun '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for Bioquell
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
N+1 Singer ,

Profile Summary

Bioquell Plc is engaged in the design, manufacture and supply of bio-decontamination and containment equipment, related products and services to the pharmaceutical, healthcare, food and defense industries, and testing services to the aerospace, telecoms, defense and other industries. The Company's operating segment is Bio-decontamination (BIO). The Company offers various products, which include Healthcare products, such as Healthcare HP Vapor Services, Healthcare HP Vapor Generators, Healthcare Patient Rooms, Healthcare Pharmacy Workstation, Healthcare Consumables/Accessories and Healthcare Archived Products; Life Science products, such as Life Sciences Aseptic Workstation, Life Sciences HP Vapor Services, Life Sciences Materials Transfer, Life Sciences HP Vapor Generators, Life Sciences Consumables/Accessories and Archived Products, and Defense products, such as Defense CBRN Filtration, Controls, Defense Pre-filtration, and Defense Consumables and Spares.

Directors: Nicholas Adams (CEO) , Michael Roller (FID) 52, Georgina Pope (SEC) , Ian Johnson (NEC) 63, Ian Carruthers (NID) , Simon Constantine (NID) 55, Christopher Mills (NID) 65,

No. of Employees: 213 No. of Shareholders: n/a

Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated June 2, 1925
Shares in Issue 22,352,987
Free Float 15.5m (69.4%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Fledgling , FTSE Fledgling Ex Investment Trusts ,
Exchange London Stock Exchange (Full)
Eligible for an ISA? a SIPP?

BQE Share Price Performance BQEQuote
0.0  0.0%
Traded 12:00am · Minimum 15 min delayed · NMS: 1.50k

Latest BQE News Announcements (delayed)

Upcoming BQE Events
Tuesday 23rd April, 2019 (estimate)
Bioquell PLC Annual Shareholders Meeting

Recent ↓
Friday 27th July, 2018 (estimate)
Half Year 2018 Bioquell PLC Earnings Release
Monday 23rd April, 2018
Bioquell PLC Annual Shareholders Meeting
Wednesday 7th March, 2018
Full Year 2017 Bioquell PLC Earnings Release
Wednesday 26th July, 2017
Half Year 2017 Bioquell PLC Earnings Release
Tuesday 7th March, 2017
Full Year 2016 Bioquell PLC Earnings Release
Wednesday 24th August, 2016
Half Year 2016 Bioquell PLC Earnings Release
Friday 10th June, 2016
Bioquell PLC Annual Shareholders Meeting
Thursday 4th June, 2015
Dividend For BQE.L
Monday 18th May, 2015
Bioquell PLC Annual Shareholders Meeting
Tuesday 5th May, 2015
Bioquell PLC Annual Shareholders Meeting
Wednesday 4th June, 2014
Dividend For BQE.L

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.

Should you buy BQE

Access BQE Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis